April 29, 2014; 82 (17) Special Article
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders
Report of the Guideline Development Subcommittee of the American Academy of Neurology
Barbara S. Koppel, John C.M. Brust, Terry Fife, Jeff Bronstein, Sarah Youssof, Gary Gronseth, David Gloss
First published April 28, 2014, DOI: https://doi.org/10.1212/WNL.0000000000000363
Barbara S. Koppel
From the Department of Neurology (B.S.K.), New York Medical College, New York; the Department of Neurology (J.C.M.B.), Columbia University College of Physicians & Surgeons, New York Neurological Institute, New York; University of Arizona College of Medicine (T.F.), Phoenix; the Department of Neurology (J.B.), David Geffen School of Medicine at University of California Los Angeles, The VA Greater Los Angeles Healthcare System; the Department of Neurology (S.Y.), University of New Mexico Health Sciences Center, Albuquerque; the Department of Neurology (G.G.), University of Kansas School of Medicine, Kansas City; and the Department of Neurology (D.G.), Geisinger Health System, Danville, PA.
John C.M. Brust
From the Department of Neurology (B.S.K.), New York Medical College, New York; the Department of Neurology (J.C.M.B.), Columbia University College of Physicians & Surgeons, New York Neurological Institute, New York; University of Arizona College of Medicine (T.F.), Phoenix; the Department of Neurology (J.B.), David Geffen School of Medicine at University of California Los Angeles, The VA Greater Los Angeles Healthcare System; the Department of Neurology (S.Y.), University of New Mexico Health Sciences Center, Albuquerque; the Department of Neurology (G.G.), University of Kansas School of Medicine, Kansas City; and the Department of Neurology (D.G.), Geisinger Health System, Danville, PA.
Terry Fife
From the Department of Neurology (B.S.K.), New York Medical College, New York; the Department of Neurology (J.C.M.B.), Columbia University College of Physicians & Surgeons, New York Neurological Institute, New York; University of Arizona College of Medicine (T.F.), Phoenix; the Department of Neurology (J.B.), David Geffen School of Medicine at University of California Los Angeles, The VA Greater Los Angeles Healthcare System; the Department of Neurology (S.Y.), University of New Mexico Health Sciences Center, Albuquerque; the Department of Neurology (G.G.), University of Kansas School of Medicine, Kansas City; and the Department of Neurology (D.G.), Geisinger Health System, Danville, PA.
Jeff Bronstein
From the Department of Neurology (B.S.K.), New York Medical College, New York; the Department of Neurology (J.C.M.B.), Columbia University College of Physicians & Surgeons, New York Neurological Institute, New York; University of Arizona College of Medicine (T.F.), Phoenix; the Department of Neurology (J.B.), David Geffen School of Medicine at University of California Los Angeles, The VA Greater Los Angeles Healthcare System; the Department of Neurology (S.Y.), University of New Mexico Health Sciences Center, Albuquerque; the Department of Neurology (G.G.), University of Kansas School of Medicine, Kansas City; and the Department of Neurology (D.G.), Geisinger Health System, Danville, PA.
Sarah Youssof
From the Department of Neurology (B.S.K.), New York Medical College, New York; the Department of Neurology (J.C.M.B.), Columbia University College of Physicians & Surgeons, New York Neurological Institute, New York; University of Arizona College of Medicine (T.F.), Phoenix; the Department of Neurology (J.B.), David Geffen School of Medicine at University of California Los Angeles, The VA Greater Los Angeles Healthcare System; the Department of Neurology (S.Y.), University of New Mexico Health Sciences Center, Albuquerque; the Department of Neurology (G.G.), University of Kansas School of Medicine, Kansas City; and the Department of Neurology (D.G.), Geisinger Health System, Danville, PA.
Gary Gronseth
From the Department of Neurology (B.S.K.), New York Medical College, New York; the Department of Neurology (J.C.M.B.), Columbia University College of Physicians & Surgeons, New York Neurological Institute, New York; University of Arizona College of Medicine (T.F.), Phoenix; the Department of Neurology (J.B.), David Geffen School of Medicine at University of California Los Angeles, The VA Greater Los Angeles Healthcare System; the Department of Neurology (S.Y.), University of New Mexico Health Sciences Center, Albuquerque; the Department of Neurology (G.G.), University of Kansas School of Medicine, Kansas City; and the Department of Neurology (D.G.), Geisinger Health System, Danville, PA.
David Gloss
From the Department of Neurology (B.S.K.), New York Medical College, New York; the Department of Neurology (J.C.M.B.), Columbia University College of Physicians & Surgeons, New York Neurological Institute, New York; University of Arizona College of Medicine (T.F.), Phoenix; the Department of Neurology (J.B.), David Geffen School of Medicine at University of California Los Angeles, The VA Greater Los Angeles Healthcare System; the Department of Neurology (S.Y.), University of New Mexico Health Sciences Center, Albuquerque; the Department of Neurology (G.G.), University of Kansas School of Medicine, Kansas City; and the Department of Neurology (D.G.), Geisinger Health System, Danville, PA.
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders
Report of the Guideline Development Subcommittee of the American Academy of Neurology
Barbara S. Koppel, John C.M. Brust, Terry Fife, Jeff Bronstein, Sarah Youssof, Gary Gronseth, David Gloss
Neurology Apr 2014, 82 (17) 1556-1563; DOI: 10.1212/WNL.0000000000000363
Citation Manager Formats
Make Comment
See Comments

Article Figures & Data
Tables
Additional Files
Data Supplement
Six tables, four appendices, references; five PDF files and one Microsoft Excel file.
Neurology® data supplements are not copyedited before publication. Published editorials and translations have been copyedited.
© 2014 American Academy of Neurology.
Files in this Data Supplement:- Tables e-1 to e-5 - PDF file
- Appendices e-1 to e-2 - PDF file
- Appendix e-3 - PDF file
- Appendix e-4 - PDF file
- e-References - PDF file
- Table e-6 - Microsoft Excel file
PODCAST
Disputes & Debates: Rapid online correspondence
No comments have been published for this article.
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.